Scylla Life Science Private Limited - Company Profile

It is a trading private limited company based in New Delhi, Delhi, India, established in 2014.
2014 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Scylla Life Science Private Limited

Scylla Life Science Private Limited, a active private limited company, was established on 14 November 2014 in New Delhi, Delhi, India. Engaging in wholesale within the trade sector, it holds CIN: U51909DL2014PTC273202. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Faiyaz Khan (Additional Director), Sarfaraj Ahmad Khan (Director). Past directors included Rakesh Kumar, Vivek Gangwar, Sheshank Gangwar. Its latest AGM occurred on 31 December 2019, with the balance sheet filed on 31 March 2019. It is based at H. No.- 2251/6 E, 2Nd Floor , Mandir Wali Gali, Sahdipur, New Delhi, Delhi, 110008.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909DL2014PTC273202

  • Registration Number

    273202

  • Incorporation Date

    14 November 2014

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 3 Months
  • Last Filing with ROC 31 Mar 2019
Company report

Scylla Life Science Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Scylla Life Science Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Scylla Life Science Private Limited?
Current Directors
Name Designation Appointment Date Status
Faiyaz Khan Additional Director 01 Mar 2020 Current
Sarfaraj Ahmad Khan Director 14 Nov 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 02 Mar 2020 Past
Pramod Abcsdd Director 29 Mar 2015 Past
Pramod Abcsdd Director 29 Mar 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Scylla Life Science.

Scylla Life Science Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Scylla Life Science revenue growth over time
Scylla Life Science profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Scylla Life Science?

In 2017, Scylla Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Scylla Life Science?

Unlock and access historical data on people associated with Scylla Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Scylla Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scylla Life Science's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Scylla Life Science
Recent Activity within the Organization
  • Director Appointment

    The activity Faiyaz Khan was appointed as a Additional Director was appointed as a Additional Director on 01 Mar 2020 & has been associated with this company since 5 years 11 months . was completed.

  • Annual General Meeting

    Progress on Scylla Life Science Private Limited last Annual general meeting of members was held on 31 Dec 2019 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Scylla Life Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Delhi. was completed.

  • Director Appointment

    The activity Sarfaraj Ahmad Khan was appointed as a Director was appointed as a Director on 14 Nov 2014 & has been associated with this company since 11 years 3 months . was completed.

  • Company Incorporation

    Progress on Scylla Life Science Private Limited was registered on 14 Nov 2014 with Roc Delhi & aged 11 years 3 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Scylla Life Science Private Limited?

The CIN of Scylla Life Science Private Limited is U51909DL2014PTC273202.

Where is Scylla Life Science Private Limited headquartered?

Scylla Life Science Private Limited is headquartered at H. No.- 2251/6 E, 2Nd Floor , Mandir Wali Gali, Sahdipur, New Delhi, Delhi, 110008.

When was Scylla Life Science Private Limited incorporated?

Scylla Life Science Private Limited was incorporated on 14 November 2014.

Who are the current directors of Scylla Life Science Private Limited?

The current directors of Scylla Life Science Private Limited are

What is the primary industry of Scylla Life Science Private Limited?

The primary industry of Scylla Life Science Private Limited is Trade.

Is Scylla Life Science Private Limited a listed company?

Scylla Life Science Private Limited is unlisted.

What is the capital structure of Scylla Life Science Private Limited?

The authorized capital of Scylla Life Science Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Scylla Life Science Private Limited?

The compliance status of Scylla Life Science Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available